Neumann et al. [5] suggested that routine analysis for mutations of the RET, VHL, SDHD, and SDHB genes in patients with apparently sporadic presentation of pheochromocytoma should be considered as the clinical standard of care. Here, SDHD is linked to pheochromocytoma.